Adil J. Akhtar, MD

1 POSTS 0 COMMENTS

Adil J. Akhtar, MD, is an Oncologist and Palliative Care Expert. He is Associate Professor, Department of Medical Oncology & Hematology, Oakland University-William Beaumont School of Medicine. Director, Inpatient Clinical Operations, Karmanos-McLaren Oakland Cancer Center in Michigan. Chief, Division of Palliative & End of Life Care, Michigan Health Professionals. Akhtar’s medical specializations are oncology, palliative care and end of life/hospice care.

Doctor discussing treatment options with a patient.

Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA...

Adil J. Akhtar, MD - July 18, 2019

LATEST NEWS

Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors

Editorial Team - December 1, 2023

Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...

Editorial Team - November 30, 2023

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Peter Hofland - November 25, 2023

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Editorial Team - November 24, 2023

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Brandon H. McNaughton, Ph.D. - November 23, 2023

Press Releases | Cancer

Ronald A. Murphy DMD Supports Battles Against Poverty and Illiteracy December 6, 2023
Dr. Ronald Murphy has joined together with the Christmas Wish to bring great reading materials to our youth in need. The Christmas Wish has been serving their community and making wishes come true for kids for over 50 years. "The Christmas Wish started as the Kid's Crusade Foundation for...
Triage Cancer® Launches Triage Health Program to Provide Free Education on the Legal and Practical Issues of a Major Medical Diagnosis December 6, 2023
Triage Cancer, a national nonprofit dedicated to providing free education and support to those affected by cancer, today announced the launch of Triage Health. Triage Health is designed to ensure that individuals diagnosed with any type of chronic or serious medical condition have a place...
Breast International Group (BIG) Highlights Innovations and Challenges in Breast Cancer Research, Exclusive Interview by Xtalks December 5, 2023
In an interview by Xtalks, Dr. David Cameron, Chair of the Breast International Group (BIG), shared valuable insights into the current state of breast cancer research, emphasizing the role of clinical trials and the integration of patient perspectives in research. BIG's efforts, as...

Adil J. Akhtar, MD

Erdafitinib, the First-Ever Targeted Therapy for Bladder Cancer, Receives Accelerated FDA...

LATEST NEWS

Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors

Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Are The Catholic Church and Its Hospitals A Marriage Made in Heaven?

Microbubbles: The Unlikely Key to Providing Accessible and Effective Cancer Treatments

Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors

Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...

Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...